Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael Fischbach
AddedFeb 17, 2024
UpdatedMay 31, 2026
Michael Fischbach

Michael Fischbach

Board Member, Revolution Medicines

Crunchbase

Michael Fischbach's Career

Revolution Medicines
Revolution Medicines

Redwood City, CA, US

Board Member· Board
Federation Bio
Federation Bio

South San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael Fischbach's Career

Revolution Medicines
Revolution Medicines
Public$1.1B2462014Redwood City, CA, US
Board Member· Board

Recent news

Reed Jobs would rather talk about curing cancer than his last nameTechCrunch · 2026

Leadership at Revolution Medicines

Barbara WeberBarbara WeberBoard Member
Liz McKee AndersonLiz McKee AndersonBoard Member
Martin BurkeMartin BurkeBoard Member
Eric T. SchmidtEric T. SchmidtBoard Member
Mark A. GoldsmithMark A. GoldsmithBoard Member
Kevan ShokatKevan ShokatBoard Member
Federation Bio
Federation Bio
Series A$50M462019South San Francisco, CA, US
Board Member· Board

Recent news

Indian drone startup Raphe mPhibr raises $100M as military UAV demand soarsTechCrunch · 2025

Leadership at Federation Bio

Patrick ZhangPatrick ZhangBoard Member
Racquel BrackenRacquel BrackenCo-Founder
Bryan RobertsBryan RobertsBoard Member
Dylan DoddDylan DoddCo-Founder
John StuelpnagelJohn StuelpnagelBoard Member
Emily Drabant ConleyEmily Drabant ConleyCEO

Similar to Federation Bio

Petri BioPetri BioLos Angeles, CA, USTherapeuticsest. 2019Petri BioLos Angeles, CA, US · est. 2019

Petri Bio: A biotech firm innovating gut microbe-based therapeutics.

Seed · $255k3
MarvelBiomeMarvelBiomeWoburn, MA, USTherapeuticsest. 2019MarvelBiomeWoburn, MA, US · est. 2019

MarvelBiome: A biopharmaceutical company harnessing microbial power for innovative disease treatments.

Seed · $3.1M9
Naked BiomeNaked BiomeCacheu Region, GWTherapeuticsest. 2015Naked BiomeCacheu Region, GW · est. 2015

Naked Biome: A therapeutics company advancing microbiome-based treatments for skin diseases.

Seed · $11.1M1
Microbiome TherapeuticsMicrobiome TherapeuticsBroomfield, CO, USMedical Researchest. 2009Microbiome TherapeuticsBroomfield, CO, US · est. 2009

Microbiome Therapeutics LLC: A US-based medical research firm specializing in metabolic disease solutions.

Series B · $3M30

Michael Fischbach's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Michael Fischbach

Patrick BrownPatrick BrownBoard Member · Impossible FoodsMichael SnyderMichael SnyderScientific Co-founder · QuinnAndrew HesselAndrew HesselBoard Member · Singularity UniversityJohn KuriyanJohn KuriyanBoard Member · NurixCynthia FriendCynthia FriendBoard Member · Bruker BioSpinThomas CechThomas CechBoard Member · Merck & CO INC Cedear EAC 5 RE